BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 23785226)

  • 1. Formulary evaluation using a class review approach: experience and results from an academic medical center.
    Persson EL; Miller KS; Nieman JA; Sgourakis AP; Akkerman SR
    P T; 2013 Apr; 38(4):213-6. PubMed ID: 23785226
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The formulary decision-making process in a US academic medical centre.
    Nash DB; Catalano ML; Wordell CJ
    Pharmacoeconomics; 1993 Jan; 3(1):22-35. PubMed ID: 10146985
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Implementation of a formulary management process.
    Karel LI; Delisle DR; Anagnostis EA; Wordell CJ
    Am J Health Syst Pharm; 2017 Aug; 74(16):1245-1252. PubMed ID: 28790076
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expediting Formulary Standardization in a Multihospital Health System Using Layered Learners.
    Hays AJ; Smith JR; Guth RM; Samet SE
    P T; 2018 Mar; 43(3):163-167. PubMed ID: 29491699
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Total formulary review--the easy way.
    Chase K; Meyer JD; Kelly WN
    Hosp Pharm; 1984 Mar; 19(3):159-62. PubMed ID: 10265845
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Developing drug formularies for the "National Medical Holding" JSC.
    Akhmadyar NS; Khairulin BE; Amangeldy-Kyzy S; Ospanov MA
    Int J Risk Saf Med; 2015; 27 Suppl 1():S51-2. PubMed ID: 26639709
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Implementation of a high-impact medication therapy subcommittee within a large academic medical center.
    Mernick F; Akrap A; MacCormack-Gagnon J
    Am J Health Syst Pharm; 2023 Jan; 80(1):e46-e52. PubMed ID: 36087114
    [TBL] [Abstract][Full Text] [Related]  

  • 8. From a to z: medication cost-management strategies for disproportionate share hospitals.
    Henry A; Erowele GI; Ndefo UA; Milton-Brown J; Anassi E; Green W; Alvidrez A; Okpara AU
    Am Health Drug Benefits; 2011 May; 4(3):172-80. PubMed ID: 25126349
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Strategies for success in creating an effective multihospital health-system pharmacy and therapeutics committee.
    Leonard MC; Thyagarajan R; Wilson AJ; Sekeres MA
    Am J Health Syst Pharm; 2018 Apr; 75(7):451-455. PubMed ID: 29572313
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of economic predictions to make formulary decisions.
    Picone MF; Wisniewski CS; Hayes GL
    Am J Health Syst Pharm; 2019 Feb; 76(Supplement_1):S15-S20. PubMed ID: 30753317
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Formulary decisions for pre-1938 medications.
    Culley CM; Carroll BA; Skledar SJ
    Am J Health Syst Pharm; 2008 Jul; 65(14):1363-7. PubMed ID: 18593683
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ohio hospital formularies: an analysis of structure, process, and outcome.
    Parrish RH; Berger BA
    Hosp Pharm; 1985 Aug; 20(8):600-3, 606-11. PubMed ID: 10289647
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development and implementation of a comprehensive, criteria-based drug-use review program.
    Todd MW; Keith TD; Foster MT
    Am J Hosp Pharm; 1987 Mar; 44(3):529-35. PubMed ID: 3471089
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug formulary decision-making: Ethnographic study of 3 pharmacy and therapeutics committees.
    Schiff GD; Tripathi JB; Galanter W; Paek JL; Pontikes P; Fanikos J; Matta L; Lambert BL
    Am J Health Syst Pharm; 2019 Apr; 76(8):537-542. PubMed ID: 30915453
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Managing conflicts of interest in pharmacy and therapeutics committees: A proposal for multicentre formulary development.
    Friesen P; Caplan AL; Miller JE
    J Clin Pharm Ther; 2020 Apr; 45(2):249-255. PubMed ID: 31657022
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Implementation of an outpatient prescription drug formulary in a managed-care system.
    Black J; Griffin T; Beisel NW; Bartels MD
    Am J Hosp Pharm; 1988 Mar; 45(3):561-5. PubMed ID: 3130754
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Implementation of an integrated pharmacy supply management strategy.
    Amerine LB; Calvert DR; Pappas AL; Lee SM; Valgus JM; Savage SW
    Am J Health Syst Pharm; 2017 Dec; 74(24):2071-2075. PubMed ID: 29222365
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of an Innovative Pharmaceutical Class Scoring Tool for Prioritized Annual Formulary Review.
    Sheldon H; Kostrzewa A; Werner S; Audley T; Biggs A; Mancuso T; Picone MF
    Innov Pharm; 2022; 13(2):. PubMed ID: 36654702
    [No Abstract]   [Full Text] [Related]  

  • 19. Impact of a transition to more restrictive drug formulary on therapy discontinuation and medication adherence.
    Shirneshan E; Kyrychenko P; Matlin OS; Avila JP; Brennan TA; Shrank WH
    J Clin Pharm Ther; 2016 Feb; 41(1):64-9. PubMed ID: 26778812
    [TBL] [Abstract][Full Text] [Related]  

  • 20. INTEGRATING HEALTH TECHNOLOGY ASSESSMENT PRINCIPLES IN FORMULARY MANAGEMENT.
    Teng M; Khoo AL; Zhao YJ; Lin L; Lim BP
    Int J Technol Assess Health Care; 2016 Jan; 32(1-2):81-7. PubMed ID: 27001376
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.